The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
The burdens of cancer therapy: Clinical and economic outcomes of chemotherapy‐induced mucositis
Open accessAbstract
BACKGROUND: Mucositis is a common but poorly studied problem among patients with solid tumors. The authors examined the clinical and economic outcomes of oral and gastrointestinal (GI) mucositis among patients receiving myelosuppressive chemotherapy. METHODS: A retrospective, random sample of 599 patients who developed chemotherapy‐induced myelosuppression was followed for development of oral or GI mucositis and for development of subsequent episodes of bleeding or infection. Multilevel regression models of the risk of bleeding and infection were fit with chemotherapy cycles nested within patients. RESULTS: Mucositis developed during 37% of 1236 cycles of chemotherapy. Episodes of bleeding were significantly more common during cycles with GI mucositis than during cycles without GI mucositis (13% vs. 8%; P = 0.04). Episodes of infection were significantly more common during cycles with mucositis (especially GI mucositis) than during cycles without mucositis (73% vs. 36%; P < 0.0001). The mean durations of hospitalization were 4 days, 6 days, and 12 days during cycles with no mucositis, oral mucositis, and GI mucositis, respectively. After accounting for the depth and duration of myelosuppression and for other predictive factors, GI mucositis was associated with both bleeding (odds ratio [OR], 2.0; P = 0.01) and infection (OR, 2.24; P < 0.0001), whereas oral mucositis was associated with infection only (OR, 2.4; P < 0.0001). CONCLUSIONS: Mucositis was clinically and economically significant among patients with solid tumors who were receiving myelosuppressive chemotherapy. New preventive and therapeutic agents are needed. Cancer 2003;98:1531–9. © 2003 American Cancer Society. DOI 10.1002/cncr.11671
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zubrod, C. G., Schneiderman, M., Frei, E., Brindley, C., Lennard Gold, G., Shnider, B., Oviedo, R., Gorman, J., Jones, R., Jonsson, U., et al. (1960) · Journal of Chronic Diseases · doi:10.1016/0021-9681(60)90137-5 · Cited by 1,034
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
Sonis, S. T., Oster, G., Fuchs, H., Bellm, L., Bradford, W. Z., Edelsberg, J., Hayden, V., Eilers, J., Epstein, J. B., LeVeque, F. G., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2201 · Cited by 678
Patient reports of complications of bone marrow transplantation
Bellm, L. A., Epstein, J. B., Rose-Ped, A., Martin, P., & Fuchs, H. J. (2000) · Supportive Care in Cancer · doi:10.1007/s005209900095 · Cited by 366
Pizzo, P. A., Armstrong, D., Bodey, G., Pauw, B. D., Feld, R., Glauser, M., Gaya, H., Karp, J., Klastersky, J., Todeschini, G., et al. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.3.397 · Cited by 277
Quality of life and oral function following radiotherapy for head and neck cancer
Epstein, J. B., Emerton, S., Kolbinson, D. A., Le, N. D., Phillips, N., Stevenson-Moore, P., & Osoba, D. (1999) · Head & Neck · doi:10.1002/(sici)1097-0347(199901)21:1<1::aid-hed1>3.0.co;2-4 · Cited by 270
McGuire, D. B., Altomonte, V., Peterson, D., Wingard, J. R., Jones, R., & Grochow, L. B. (1993) · PubMed · Cited by 160
Savarese, D. M. F., Hsieh, C., & Stewart, F. M. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2981 · Cited by 106
Viscoli, C., Bruzzi, P., & Glauser, M. P. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00292-8 · Cited by 38
Elting, L. S., Martin, C. G., Kurtin, D., Cantor, S. B., Rubenstein, E. B., Rodriguez, S., Kanesan, K., Vadhan‐Raj, S., & Benjamin, R. S. (2002) · Cancer · doi:10.1002/cncr.10603 · Cited by 34
Self-citationHarrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
Cited by
Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., Bekele, B. N., Raber-Durlacher, J., Donnelly, J. P., Rubenstein, E. B., et al. (2004) · Cancer · doi:10.1002/cncr.20162 · Cited by 1,417
Self-citationSonis, S. T. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1318 · Cited by 1,361
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Elad, S., Cheng, K. K. F., Lalla, R. V., Yarom, N., Hong, C., Logan, R. M., Bowen, J., Gibson, R., Saunders, D. P., Zadik, Y., et al. (2020) · Cancer · doi:10.1002/cncr.33100 · Cited by 1,336
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Lalla, R. V., Bowen, J., Barasch, A., Elting, L., Epstein, J., Keefe, D. M., McGuire, D. B., Migliorati, C., Nicolatou‐Galitis, O., Peterson, D. E., et al. (2014) · Cancer · doi:10.1002/cncr.28592 · Cited by 1,110
Self-citationManagement of Oral Mucositis in Patients Who Have Cancer
Lalla, R. V., Sonis, S. T., & Peterson, D. E. (2008) · Dental Clinics of North America · doi:10.1016/j.cden.2007.10.002 · Cited by 602
Elting, L. S., Cooksley, C. D., Chambers, M. S., & Garden, A. S. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.053 · Cited by 533
Self-citationChemotherapy‐driven dysbiosis in the intestinal microbiome
Montassier, E., Gastinne, T., Vangay, P., Al‐Ghalith, G. A., Bruley des Varannes, S., Massart, S., Moreau, P., Potel, G., de La Cochetière, M. F., Batard, E., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13302 · Cited by 515
Hassett, M. J., O'Malley, A. J., Pakes, J. R., Newhouse, J. P., & Earle, C. C. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj305 · Cited by 360
New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury
Cinausero, M., Aprile, G., Ermacora, P., Basile, D., Vitale, M. G., Fanotto, V., Parisi, G., Calvetti, L., & Sonis, S. T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00354 · Cited by 290
The anatomy and physiology of normal and abnormal swallowing in oropharyngeal dysphagia
Sasegbon, A., & Hamdy, S. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13100 · Cited by 287
Logan, R. M., Stringer, A. M., Bowen, J. M., Yeoh, A. S.-J., Gibson, R. J., Sonis, S. T., & Keefe, D. M. K. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.03.001 · Cited by 279
Bjordal, J. M., Bensadoun, R.-J., Tunèr, J., Frigo, L., Gjerde, K., & Lopes-Martins, R. A. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1202-0 · Cited by 272
Liu, Y.-Q., Wang, X.-L., He, D.-H., & Cheng, Y.-X. (2021) · Phytomedicine · doi:10.1016/j.phymed.2020.153402 · Cited by 259
Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK
Califano, R., Tariq, N., Compton, S., Fitzgerald, D. A., Harwood, C. A., Lal, R., Lester, J., McPhelim, J., Mulatero, C., Subramanian, S., et al. (2015) · Drugs · doi:10.1007/s40265-015-0434-6 · Cited by 152
A systematic review of orofacial pain in patients receiving cancer therapy
Epstein, J. B., Hong, C., Logan, R. M., Barasch, A., Gordon, S. M., Oberlee-Edwards, L., McGuire, D., Napenas, J. J., Elting, L. S., Spijkervet, F. K. L., et al. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0897-7 · Cited by 120
Self-citationHunt, J. E., Holst, J. J., Jeppesen, P. B., & Kissow, H. (2021) · Biomedicines · doi:10.3390/biomedicines9040383 · Cited by 65
Metadata
- Authors
- Elting, L. S., Cooksley, C., Chambers, M., Cantor, S. B., Manzullo, E., & Rubenstein, E. B.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-08-14
- Volume
- 98
- Issue
- 7
- Pages
- 1531-1539
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1975245593
- Cited by
- 617
- References
- 10
- FWCI
- 16.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.